Quarterly report pursuant to Section 13 or 15(d)

Stock-Based Compensation

v3.20.2
Stock-Based Compensation
6 Months Ended
Jun. 30, 2020
Share-based Payment Arrangement [Abstract]  
Stock-Based Compensation

12. Stock-Based Compensation

 

Equity Incentive Plans – The Company’s 2013 Equity Compensation Plan (the “2013 Plan”) was adopted for the purpose of providing equity incentives to employees, officers, directors and consultants including options, restricted stock, restricted stock units, stock appreciation rights, other equity awards, annual incentive awards and dividend equivalents. The Company amended the 2013 Plan to increase the number of authorized shares of common stock under the Plan from 225,000 shares to 615,000 shares, which the Company’s stockholders approved on June 26, 2017. The Company further amended the 2013 Plan to increase the number of authorized shares of common stock under the Plan by 300,000 shares, which the Company’s stockholders approved and ratified on November 8, 2018. The Company is now authorized to issue 915,000 shares under the amended 2013 Plan.

 

Stock Options

 

The fair value of options is estimated on the date of grant using the Black-Scholes option pricing model. The valuation determined by the Black-Scholes pricing model is affected by the Company’s stock price as well as assumptions regarding a number of highly complex and subjective variables. These variables include, but are not limited to, expected stock price volatility over the term of the awards, and actual and projected employee stock option exercise behaviors. The risk free rate is based on the U.S. Treasury rate for the expected life at the time of grant, volatility is based on the average long-term implied volatilities of peer companies, the expected life is based on the estimated average of the life of options using the simplified method, and forfeitures are estimated on the date of grant based on certain historical data. The Company utilizes the simplified method to determine the expected life of its options due to insufficient exercise activity during recent years as a basis from which to estimate future exercise patterns. The expected dividend assumption is based on the Company’s history and expectation of dividend payouts.

 

The following table summarizes the Company’s stock option activity for the six months ended June 30, 2020 and 2019:

 

                Weighted Average        
          Weighted     Remaining        
          Average     Contractual     Aggregate  
    Number of     Exercise     Life     Intrinsic  
    Options     Price     (in Years)     Value  
Outstanding - January 1, 2020     295,793     $ 8.88       7.5     $ -  
Granted     30,000       3.69       10.0          
Exercised     -       -       -          
Forfeited     (259,667 )     9.21       -          
Outstanding - June 30, 2020     66,126     $ 5.24       8.8     $ -  
                                 
Exercisable at June 30, 2020     26,126     $ 8.18       7.5     $ -  

 

          Weighted     Weighted Average        
          Average     Remaining Contractual     Aggregate  
    Number of     Exercise     Life     Intrinsic  
    Options     Price     (in Years)     Value  
Outstanding - January 1, 2019     499,439     $ 6.94     $ 9.0     $ -  
Granted     30,000       2.23       -          
Exercised     -       -       -          
Forfeited     (210,313 )     3.98       -          
Outstanding - June 30, 2019     319,126     $ 8.44       8.1     $ 8,400  
                                 
Exercisable at June 30, 2019     252,459     $ 9.97       7.8     $ 2,800  

 

The fair value of stock options granted during the six months ended June 30, 2020 were estimated on the date of grant using the Black-Scholes option pricing model. The fair value of stock options is being amortized on a straight-line basis over the requisite service period of the awards. The fair value of share options were estimated using the following assumptions:

 

    Six Months Ended  
    June 30, 2020  
Expected dividend yield     -  
Risk-free interest rate     0.33 %
Expected volatility     111.55 %
Expected term (in years)     5.75  
Grant-date fair value of stock options awarded   $ 3.03  

 

During the six months ended June 30, 2020, vested stock options of 259,667 with a weighted average exercise price of $9.21 were forfeited. Total unrecognized pre-tax stock-based compensation expense related to unvested stock options at June 30, 2020 was $102,297, which is expected to be recognized through the second quarter of 2023.

 

Warrants

 

As of June 30, 2020 and December 31, 2019, 125,000 warrants were outstanding and exercisable with an exercise price of $20.00 per share. The aggregate intrinsic value was $0 and the warrants are scheduled to expire on December 27, 2021.

 

Restricted Stock

 

As of June 30, 2020 and 2019, the following is a summary of restricted stock activity:

 

    Number of  
    Shares  
Outstanding - January 1, 2020     27,319  
Granted     306,775  
Forfeited     -  
Vested     (127,319 )
Outstanding - June 30, 2020     206,775  

 

    Number of  
    Shares  
Outstanding - January 1, 2019     60,651  
Granted     47,568  
Forfeited     (13,865 )
Vested     (27,761 )
Outstanding - June 30, 2019     66,593  

 

During the six months ended June 30, 2020, 127,319 in restricted stock units vested. During the six months ended June 30, 2020, 306,775 restricted stock units were granted, of which 100,000 restricted stock units vested upon date of grant.

 

Additionally, the Company recorded non-cash pre-tax stock-based compensation expense of $374,397 and $72,570 for the six months ended June 30, 2020 and June 30, 2019, as a component of general and administrative expenses in the accompanying statements of operations, pertaining to restricted stock.

 

Total unrecognized pre-tax stock-based compensation expense related to unvested restricted stock at June 30, 2020 was $757,603 and is expected to be recognized through the second quarter of 2022.